If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Patuzzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Melanoma Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lymph Nodes Medicine & Life Sciences
Vaccination Medicine & Life Sciences
Lymph Node Excision Medicine & Life Sciences
Peptides Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2018

  • 1373 Citations
  • 22 h-Index
  • 47 Article

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P. A., Locati, L. D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L. & Bossi, P., Jul 2018, In : European Journal of Cancer. 97, p. 7-15 9 p.

Research output: Contribution to journalArticle

Squamous Cell Neoplasms
Skin Neoplasms
Epidermal Growth Factor Receptor
Safety
Radiotherapy

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma

Huber, V., Vallacchi, V., Fleming, V., Hu, X., Cova, A., Dugo, M., Shahaj, E., Sulsenti, R., Vergani, E., Filipazzi, P., De Laurentiis, A., Lalli, L., Di Guardo, L., Patuzzo, R., Vergani, B., Casiraghi, E., Cossa, M., Gualeni, A., Bollati, V., Arienti, F. & 7 others, De Braud, F., Mariani, L., Villa, A., Altevogt, P., Umansky, V., Rodolfo, M. & Rivoltini, L., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5505-5516 12 p.

Research output: Contribution to journalArticle

Myeloid Cells
MicroRNAs
Immunotherapy
Melanoma
Neoplasms
6 Citations (Scopus)

Prognostic factors in Merkel cell carcinoma patients undergoing sentinel node biopsy

Mattavelli, I., Patuzzo, R., Torri, V., Gallino, G., Maurichi, A., Lamera, M., Valeri, B., Bolzonaro, E., Barbieri, C., Tolomio, E., Moglia, D., Nespoli, A. M., Galeone, C., Saw, R. & Santinami, M., Aug 1 2017, In : European Journal of Surgical Oncology. 43, 8, p. 1536-1541 6 p.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Biopsy
Residual Neoplasm
Survival
Recurrence
8 Citations (Scopus)

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells

Tuccitto, A., Tazzari, M., Beretta, V., Rini, F., Miranda, C., Greco, A., Santinami, M., Patuzzo, R., Vergani, B., Villa, A., Manenti, G., Cleris, L., Giardiello, D., Alison, M., Rivoltini, L., Castelli, C. & Perego, M., Oct 1 2016, In : Stem Cells. 34, 10, p. 2449-2460 12 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Melanoma
Interleukin-10
Interleukin-6
Chemokines
19 Citations (Scopus)

Armed antibodies for cancer treatment: a promising tool in a changing era

Danielli, R., Patuzzo, R., Ruffini, P. A. D., Maurichi, A., Giovannoni, L., Elia, G., Neri, D. & Santinami, M., Jan 1 2015, In : Cancer Immunology, Immunotherapy. 64, 1, p. 113-121 9 p.

Research output: Contribution to journalArticle

Melanoma
Antibodies
Neoplasms
Therapeutics
Allergy and Immunology